Last 7 days
0.7%
Last 30 days
6.1%
Last 90 days
17.6%
Trailing 12 Months
15.7%
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MSFT | 2.1T | 204.1B | 11.55% | -7.07% | 30.98 | 10.24 | 10.38% | -5.25% |
ORCL | 237.2B | 46.1B | 1.96% | 8.47% | 26.96 | 5.15 | 11.29% | -14.28% |
CRM | 189.5B | 31.4B | 16.34% | -11.18% | 911.01 | 6.04 | 19.41% | -85.60% |
ADBE | 173.2B | 17.6B | 7.52% | -13.23% | 36.42 | 9.84 | 11.54% | -1.37% |
ZM | 20.4B | 4.4B | -5.93% | -41.37% | 196.74 | 4.64 | 7.15% | -92.46% |
AZPN | 12.1B | - | -7.60% | 30.28% | 44.35 | 17.39 | - | - |
MID-CAP | ||||||||
PLAN | 9.6B | - | -1.97% | 16.85% | -45.68 | 15.19 | - | - |
MANH | 9.2B | 767.1M | 3.22% | 4.63% | 71.04 | 11.94 | 15.59% | 16.73% |
GWRE | 6.4B | 869.9M | 7.80% | -18.19% | -32.37 | 7.38 | 13.87% | -103.37% |
APPN | 2.9B | 468.0M | -7.97% | -36.63% | -19.31 | 6.23 | 26.74% | -70.26% |
PING | 2.4B | 308.3M | 1.17% | 7.67% | -23.16 | 7.93 | 13.75% | -237.98% |
SMALL-CAP | ||||||||
ZUO | 1.2B | 383.7M | 7.01% | -39.43% | -9.85 | 3.22 | 14.43% | -50.89% |
YEXT | 1.1B | 399.9M | 31.21% | 29.01% | -13.97 | 2.84 | 4.73% | 8.15% |
UPLD | 136.0M | 317.3M | -51.83% | -75.83% | -1.99 | 0.43 | 5.06% | -17.52% |
Income Statement (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 |
Revenue | 1.8% | 5,173 | 5,082 | 4,950 | 4,759 | 4,504 |
Cost Of Revenue | 2.6% | 1,091 | 1,064 | 1,016 | 950 | 911 |
Gross Profit | 1.6% | 4,082 | 4,018 | 3,934 | 3,809 | 3,593 |
Operating Expenses | 5.4% | 3,011 | 2,856 | 2,799 | 2,706 | 2,660 |
S&GA Expenses | 3.9% | 810 | 780 | 769 | 741 | 722 |
R&D Expenses | 4.8% | 1,762 | 1,680 | 1,633 | 1,559 | 1,531 |
EBITDA | -3.9% | 1,293 | 1,345 | 1,295 | - | - |
EBITDA Margin | -5.6% | 0.25* | 0.26* | 0.27* | - | - |
Earnings Before Taxes | -4.3% | 1,067 | 1,116 | 1,102 | 1,079 | 956 |
EBT Margin | -6.0% | 0.21* | 0.22* | 0.22* | - | - |
Interest Expenses | - | 1.00 | - | - | - | - |
Net Income | -4.3% | 942 | 985 | 1,033 | 1,009 | 909 |
Net Income Margin | -6.0% | 0.18* | 0.19* | 0.21* | - | - |
Free Cahsflow | -2.7% | 1,560 | 1,602 | 1,586 | 1,581 | - |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 |
Assets | 1.6% | 9,566 | 9,418 | 9,330 | 9,210 | 8,901 |
Current Assets | 0.5% | 3,028 | 3,013 | 2,899 | 3,074 | 2,947 |
Cash Equivalents | -18.5% | 1,155 | 1,418 | 1,384 | 1,574 | 1,127 |
Inventory | 4.2% | 221 | 212 | 220 | 214 | 213 |
Net PPE | 7.0% | 517 | 483 | 487 | 492 | 478 |
Goodwill | 0.6% | 3,865 | 3,842 | 3,855 | 47.00 | 16.00 |
Liabilities | 0.7% | 3,887 | 3,859 | 3,678 | 3,599 | 3,511 |
Current Liabilities | -1.8% | 2,725 | 2,774 | 2,546 | 2,463 | 2,472 |
. Short Term Borrowings | NaN% | - | - | - | - | - |
LT Debt, Non Current | -1.2% | 21.00 | 21.00 | 22.00 | 24.00 | 24.00 |
Shareholder's Equity | 2.2% | 5,637 | 5,516 | 5,604 | 5,567 | 5,390 |
Retained Earnings | 4.9% | 5,806 | 5,534 | 5,378 | 5,158 | 4,863 |
Additional Paid-In Capital | -13.1% | 1,293 | 1,487 | 1,415 | 1,517 | 1,430 |
Shares Outstanding | 0.0% | 152 | 152 | 153 | 153 | 153 |
Minority Interest | 23.9% | 6.00 | 5.00 | 4.00 | 3.00 | 3.00 |
Cashflow (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 |
Cashflow From Operations | -2.4% | 1,698 | 1,739 | 1,716 | 1,698 | 1,474 |
Share Based Compensation | 8.4% | 497 | 459 | 430 | 388 | 357 |
Cashflow From Investing | 5.5% | -540 | -572 | -694 | -614 | -513 |
Cashflow From Financing | 1.6% | -1,098 | -1,116 | -984 | -944 | -850 |
Buy Backs | 4.6% | 1,151 | 1,100 | 932 | 855 | 760 |
75.4%
18.1%
0%
Y-axis is the maximum loss one would have experienced if Synopsys was unfortunately bought at previous high price.
26.7%
34.3%
35.5%
46.2%
FIve years rolling returns for Synopsys.
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-03-23 | MetLife Investment Management, LLC | reduced | -1.98 | 350,257 | 14,684,800 | 0.12% |
2023-03-17 | American Portfolios Advisors | reduced | -1.99 | -10,731 | 751,860 | 0.03% |
2023-03-15 | B. Riley Wealth Advisors, Inc. | added | 19.95 | 93,567 | 464,567 | 0.01% |
2023-03-10 | VICTORY CAPITAL MANAGEMENT INC | reduced | -36.39 | -41,029,500 | 81,352,500 | 0.09% |
2023-03-10 | MATHER GROUP, LLC. | reduced | -24.1 | -190,061 | 728,939 | 0.01% |
2023-03-08 | Capital Asset Advisory Services LLC | added | 49.96 | 198,197 | 541,197 | 0.04% |
2023-03-06 | OLD MISSION CAPITAL LLC | sold off | -100 | -214,000 | - | -% |
2023-03-06 | Rockefeller Capital Management L.P. | reduced | -0.34 | 90,000 | 2,275,000 | 0.01% |
2023-03-06 | NORTH STAR ASSET MANAGEMENT INC | added | 2.16 | 1,215,970 | 19,190,000 | 1.19% |
2023-03-03 | TIAA, FSB | added | 14.63 | 2,510,430 | 15,185,400 | 0.06% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 14, 2023 | price t rowe associates inc /md/ | 3.5% | 5,390,531 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 8.71% | 13,273,486 | SC 13G/A | |
Jan 25, 2023 | blackrock inc. | 8.8% | 13,430,066 | SC 13G | |
Feb 14, 2022 | price t rowe associates inc /md/ | 6.3% | 9,737,325 | SC 13G/A | |
Feb 10, 2022 | vanguard group inc | 11.13% | 17,070,637 | SC 13G/A | |
Feb 01, 2022 | blackrock inc. | 8.5% | 13,116,235 | SC 13G/A | |
Feb 16, 2021 | price t rowe associates inc /md/ | 6.9% | 10,575,131 | SC 13G/A | |
Feb 10, 2021 | vanguard group inc | 11.12% | 17,022,619 | SC 13G/A | |
Feb 01, 2021 | blackrock inc. | 8.3% | 12,777,336 | SC 13G/A | |
Feb 14, 2020 | price t rowe associates inc /md/ | 5.4% | 8,206,918 | SC 13G/A |
Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
---|---|---|---|---|---|
Very Low Inflation | 124.29 -66.76% | 156.03 -58.27% | 211.03 -43.56% | 268.24 -28.26% | 331.43 -11.36% |
Current Inflation | 113.75 -69.58% | 140.57 -62.41% | 186.29 -50.18% | 233.58 -37.53% | 286.01 -23.51% |
Very High Inflation | 100.85 -73.03% | 122.03 -67.36% | 157.35 -57.92% | 193.70 -48.20% | 234.22 -37.36% |
Date Filed | Form Type | Document | |
---|---|---|---|
Mar 02, 2023 | 4 | Insider Trading | |
Mar 02, 2023 | 4 | Insider Trading | |
Mar 02, 2023 | 4 | Insider Trading | |
Mar 02, 2023 | 4 | Insider Trading | |
Mar 02, 2023 | 4 | Insider Trading | |
Feb 28, 2023 | 4 | Insider Trading | |
Feb 23, 2023 | 8-K | Current Report | |
Feb 22, 2023 | 4 | Insider Trading | |
Feb 22, 2023 | 4 | Insider Trading | |
Feb 22, 2023 | 4 | Insider Trading |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-02-28 | Kankanwadi Sudhindra | acquired | 9,891 | 282 | 35.00 | chief accounting officer |
2023-02-28 | RUNKEL JOHN F JR | acquired | 9,891 | 282 | 35.00 | gc & corporate secretary |
2023-02-28 | Ghazi Sassine | acquired | 9,939 | 261 | 38.00 | president and coo |
2023-02-28 | MAHONEY RICHARD S. | acquired | 9,891 | 282 | 35.00 | chief revenue officer |
2023-02-28 | DE GEUS AART | acquired | 9,939 | 261 | 38.00 | chairman of the board & ceo |
2023-02-24 | Kankanwadi Sudhindra | sold | -1,444,300 | 361 | -4,000 | chief accounting officer |
2023-02-24 | Kankanwadi Sudhindra | acquired | 241,480 | 60.37 | 4,000 | chief accounting officer |
2023-02-17 | RUNKEL JOHN F JR | sold | -1,225,930 | 353 | -3,464 | gc & corporate secretary |
2023-02-17 | RUNKEL JOHN F JR | acquired | 465,599 | 134 | 3,464 | gc & corporate secretary |
2023-01-09 | Ghazi Sassine | sold | -9,612,850 | 329 | -29,136 | president and coo |
Unaudited Condensed Consolidated Statements Of Income - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | |
---|---|---|
Jan. 31, 2023 | Jan. 31, 2022 | |
Revenue: | ||
Total revenue | $ 1,361,340 | $ 1,270,255 |
Cost of revenue: | ||
Amortization of intangible assets | 18,640 | 13,360 |
Total cost of revenue | 284,354 | 256,984 |
Gross margin | 1,076,986 | 1,013,271 |
Operating expenses: | ||
Research and development | 465,329 | 383,971 |
Sales and marketing | 210,785 | 180,510 |
General and administrative | 97,364 | 81,008 |
Amortization of intangible assets | 6,717 | 9,000 |
Restructuring charges | 40,859 | 11,746 |
Total operating expenses | 821,054 | 666,235 |
Operating income | 255,932 | 347,036 |
Other income (expense), net | 23,292 | (19,793) |
Income before income taxes | 279,224 | 327,243 |
Provision (benefit) for income taxes | 10,597 | 13,902 |
Net income | 268,627 | 313,341 |
Net income (loss) attributed to non-controlling interest and redeemable non-controlling interest | (2,909) | (346) |
Net income attributed to Synopsys | $ 271,536 | $ 313,687 |
Net income per share attributed to Synopsys: | ||
Basic (in USD per share) | $ 1.78 | $ 2.05 |
Diluted (in USD per share) | $ 1.75 | $ 1.99 |
Shares used in computing per share amounts: | ||
Basic (shares) | 152,401 | 153,218 |
Diluted (shares) | 155,076 | 157,273 |
Product | ||
Revenue: | ||
Total revenue | $ 1,118,971 | $ 1,075,757 |
Cost of revenue: | ||
Cost of revenue | 174,367 | 165,399 |
Time-based products | ||
Revenue: | ||
Total revenue | 782,313 | 707,483 |
Upfront products | ||
Revenue: | ||
Total revenue | 336,658 | 368,274 |
Maintenance and service | ||
Revenue: | ||
Total revenue | 242,369 | 194,498 |
Cost of revenue: | ||
Cost of revenue | $ 91,347 | $ 78,225 |
Unaudited Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Jan. 31, 2023 | Oct. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 1,154,873 | $ 1,417,608 |
Short-term investments | 147,050 | 147,913 |
Total cash, cash equivalents and short-term investments | 1,301,923 | 1,565,521 |
Accounts receivable, net | 1,035,323 | 796,091 |
Inventories | 220,881 | 211,927 |
Prepaid and other current assets | 470,272 | 439,130 |
Total current assets | 3,028,399 | 3,012,669 |
Property and equipment, net | 516,925 | 483,300 |
Operating lease right-of-use assets, net | 586,892 | 559,090 |
Goodwill | 3,864,833 | 3,842,234 |
Intangible assets, net | 361,154 | 386,446 |
Deferred income taxes | 719,082 | 670,653 |
Other long-term assets | 488,339 | 463,695 |
Total assets | 9,565,624 | 9,418,087 |
Current liabilities: | ||
Accounts payable and accrued liabilities | 663,594 | 809,403 |
Operating lease liabilities | 66,326 | 54,274 |
Deferred revenue | 1,995,077 | 1,910,822 |
Total current liabilities | 2,724,997 | 2,774,499 |
Long-term operating lease liabilities | 603,538 | 581,273 |
Long-term deferred revenue | 172,794 | 154,472 |
Long-term debt | 20,569 | 20,824 |
Other long-term liabilities | 364,975 | 327,829 |
Total liabilities | 3,886,873 | 3,858,897 |
Redeemable non-controlling interest | 36,049 | 38,664 |
Stockholders’ equity: | ||
Preferred stock, $0.01 par value: 2,000 shares authorized; none outstanding | 0 | 0 |
Common stock, $0.01 par value: 400,000 shares authorized; 152,380 and 152,375 shares outstanding, respectively | 1,524 | 1,524 |
Capital in excess of par value | 1,292,900 | 1,487,126 |
Retained earnings | 5,805,843 | 5,534,307 |
Treasury stock, at cost: 4,881 and 4,886 shares, respectively | (1,321,180) | (1,272,955) |
Accumulated other comprehensive income (loss) | (142,333) | (234,277) |
Total Synopsys stockholders’ equity | 5,636,754 | 5,515,725 |
Non-controlling interest | 5,948 | 4,801 |
Total stockholders’ equity | 5,642,702 | 5,520,526 |
Total liabilities, redeemable non-controlling interest and stockholders’ equity | $ 9,565,624 | $ 9,418,087 |